Career history of Michael Natchus
Former positions of Michael Natchus
Companies | Position | Start | End |
---|---|---|---|
Metastatix, Inc.
Metastatix, Inc. Pharmaceuticals: MajorHealth Technology Metastatix, Inc. develops small molecule drugs to treat life-threatening diseases including cancer, HIV infection, and macular degeneration. It has developed a series of novel oral small-molecule CXCR4 inhibitors that have unprecedented biological activity in preclinical models. The company was founded in 2005 and is located in Tucker, GA. | Chief Tech/Sci/R&D Officer | - | 2009-06-21 |
Altiris Therapeutics, Inc.
Altiris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Altiris Therapeutics, Inc. develops and commercializes small-molecule drug therapies. The company was founded by Dennis Liotta, Hyunsuk Shim and James P. Snyder in 2005 and is headquartered in Atlanta, GA. | Founder | 2004-12-31 | - |
Somatocor Pharmaceuticals, Inc. | Corporate Officer/Principal | 1999-12-31 | 2000-01-01 |
Training of Michael Natchus
Virginia Polytechnic Institute & State University | Doctorate Degree |
Statistics
International
United States | 5 |
Operational
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 3 |
---|---|
Metastatix, Inc.
Metastatix, Inc. Pharmaceuticals: MajorHealth Technology Metastatix, Inc. develops small molecule drugs to treat life-threatening diseases including cancer, HIV infection, and macular degeneration. It has developed a series of novel oral small-molecule CXCR4 inhibitors that have unprecedented biological activity in preclinical models. The company was founded in 2005 and is located in Tucker, GA. | Health Technology |
Somatocor Pharmaceuticals, Inc. | |
Altiris Therapeutics, Inc.
Altiris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Altiris Therapeutics, Inc. develops and commercializes small-molecule drug therapies. The company was founded by Dennis Liotta, Hyunsuk Shim and James P. Snyder in 2005 and is headquartered in Atlanta, GA. | Health Technology |
- Stock Market
- Insiders
- Michael Natchus
- Experience